Effect of Co-Morbidities on Mortality from COVID-19 in Mexico: an Ecological Study

Nicolás Padilla-Raygoza^1*, Oscar Ulises Vega-Jimenez¹, Andrea García Juárez¹, María de Jesús Gallardo-Luna², Efraín Navarro-Olivos², Ma Guadalupe León-Verdin², Francisco J. Magos-Vázquez² and Daniel Alberto Díaz-Martínez²

¹School of Medicine, University of Celaya, México 38080.

²Secretary of Health from Guanajuato State, México, 36000.

Corresponding Author E mail: npadilla@udec.edu.mx

Abstract:

With the emergence of a SARS-CoV-2 infection pandemic in China and its spread to other countries, mortality was shown to be high and to a greater extent if there were underlying pathologies. It is said {or an ecological analytical cross-sectional study, of the open records of confirmed and discarded cases for COVID-19 of the General Directorate of Epidemiology of the Secretary of Health of Mexico. A specific mortality of 9.79% is reported; being higher in men between the ages of 20 to 59 and over 60 years. Mortality rates from underlying diseases were higher than those reported in the USA in early May 2020. Asthma was found to be a protective factor for COVID-19 mortality. It is concluded that mortality was higher in the presence of comorbidities.

Keywords: COVID-19; Co-Morbidities; Mortality; SARS-CoV-2

[ HTML Full Text]

Back to TOC